-
公开(公告)号:BG104754A
公开(公告)日:2001-05-31
申请号:BG10475400
申请日:2000-09-07
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLINGE DAGMAR , RIECHERS HARTMUT , GENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: C07D251/22 , A61K31/192 , A61K31/216 , A61K31/505 , A61K31/506 , A61K31/519 , A61K31/53 , A61P9/04 , A61P9/06 , A61P9/10 , A61P9/12 , A61P11/06 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07C59/66 , C07C59/68 , C07C69/734 , C07D213/63 , C07D239/34 , C07D239/52 , C07D239/60 , C07D405/12 , C07D491/048 , C07D403/12 , C07D213/64
Abstract: The compounds are suitable for the treatment of diseases related to the endothelial level. They are derivatives of the carbonic acid with the formula wherein R1-R6, Q, W, X, Y and Z have the meanings given in the description. The invention also relates to a method for their production. 9 claims
-
公开(公告)号:ID27965A
公开(公告)日:2001-05-03
申请号:ID20010326
申请日:1999-08-07
Applicant: BASF AG
Inventor: AMBERG WIHELM , JANSEN ROLF , KETTSCHAU GEORG , HERGENRODER STEFAN , RASCHAK MANFRED , UNGER LILIANE
IPC: C07D251/22 , A61K31/505 , A61K31/517 , A61K31/519 , A61K31/53 , A61K45/00 , A61P9/04 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07D239/34 , C07D239/52 , C07D239/60 , C07D239/70 , C07D251/52 , C07D401/12 , C07D403/12 , C07D405/12 , C07D491/048 , C07D495/04
Abstract: The invention relates to new carboxylic acid derivatives of the formula (I), where the substituents have the meaning given in the description, their production and their use as endothelin-receptor antagonists.
-
公开(公告)号:AU7655200A
公开(公告)日:2001-04-17
申请号:AU7655200
申请日:2000-09-13
Applicant: BASF AG
Inventor: KNOPP MONIKA , JANSEN ROLF
IPC: C07C67/31 , C07C67/313 , C07C67/343 , C07C69/675 , C07C69/732
-
公开(公告)号:PL340756A1
公开(公告)日:2001-02-26
申请号:PL34075698
申请日:1998-11-04
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , HILLEN HEINZ , HERGENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: C07D249/12 , A61K31/41 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/4245 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/433 , A61P9/04 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/06 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07D231/20 , C07D233/70 , C07D261/12 , C07D263/38 , C07D271/06 , C07D271/10 , C07D273/01 , C07D275/02 , C07D275/03 , C07D277/20 , C07D277/32 , C07D277/34 , C07D277/60 , C07D277/68 , C07D285/00 , C07D285/08 , C07D285/12 , C07D291/04 , C07D413/12 , C07D417/12
Abstract: The present invention relates to carboxylic acid derivatives of the formula Ithe substituents having the meanings explained in the description, preparation and use as endothelin receptor antagonists.
-
公开(公告)号:CZ20003239A3
公开(公告)日:2001-02-14
申请号:CZ20003239
申请日:1999-02-25
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLINGE DAGMAR
IPC: C07C319/14
-
公开(公告)号:NO20010622D0
公开(公告)日:2001-02-06
申请号:NO20010622
申请日:2001-02-06
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KETTSCHAU GEORG , HERGENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: C07D251/22 , A61K31/505 , A61K31/517 , A61K31/519 , A61K31/53 , A61K45/00 , A61P9/04 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07D239/34 , C07D239/52 , C07D239/60 , C07D239/70 , C07D251/52 , C07D401/12 , C07D403/12 , C07D405/12 , C07D491/048 , C07D495/04 , C07D
Abstract: The invention relates to new carboxylic acid derivatives of the formula (I), where the substituents have the meaning given in the description, their production and their use as endothelin-receptor antagonists.
-
公开(公告)号:BG103258A
公开(公告)日:2000-12-29
申请号:BG10325899
申请日:1999-03-16
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , HERGENRODER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: A61K31/505 , A61K31/506 , A61K31/519 , A61P9/04 , A61P9/08 , A61P9/12 , A61P43/00 , C07C59/66 , C07C69/734 , C07D239/34 , C07D239/52 , C07D239/60 , C07D239/70 , C07D491/04 , C07D491/048
Abstract: The derivatives of carboxylic acids have the formula where R1 means tetrazole or the group (a); R2 means hydrogen, hydroxy, amino, NH(C1-C4-alkyl), N(C1-C4-alkyl)2; halogen, C1-C4 alkyl, C2-C4 alkenyl, C1-C4 halogenalkyl, C1-C4 alkoxy, C1-C4 halogenalkoxy or C1-C4 alkylthio, or CR2 together with CR10, as shown below, form 5- or 6-member ring, N is nitrogen or methine, Y is nitrogen or methine. Z is nitrogen or CR10, where R10 is hydrogen or C1-C4 alkyl or CR10 together with CR2 or with CR3 form 5- or 6-member alkylene or alkenyl ring where one or more methylene groups can be substituted with oxygen, sulphur, -NH or -N(C1-C4-alkyl), R3 is hydrogen, hydroxy, amino, NH(C1-C4-alkyl), N(C1-C4-alkyl), N(C1-C4-alkyl)2, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 hydroxyalkyl, C1-C4 halogenalkyl, C1-C4 alkoxy, C1-C4 halogenalkoxy, C1-C4 alkylthio or CR3 together with CR10, as indicated above, form 5- or 6-member ring, R4 & R5 (which can be the same or different) are phenyl, optionally substituted, or phenyl or naphthyl which are interconnected in orthoposition by a direct bond, by methylene, ethylene or ethenyl group, with oxygen or sulphur or by the group SO2-, NH- or N-alkyl, C3-C8-cycloalkyl, optionally substituted, R6 is C3-C8 cycloalkyl, optionally substituted, phenyl or naphthyl, optionally substituted, or 5- or 6-member heteroaromatic ring containing from one to three nitrogen atoms and/or one sulphur or oxygen atom, W is sulphur or oxygen, Q is a dividing group which by length corresponds to a C2-C4 chain. The invention also relates to physiologically acceptable salts of these compounds, as well as to their pure enantiomer or diastereomer forms, to their preparation and application as mixed ETA/ETB-receptor antagonists. 10 claims
-
公开(公告)号:CZ20003219A3
公开(公告)日:2000-12-13
申请号:CZ20003219
申请日:1999-02-25
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLINGE DAGMAR , RIECHERS HARTMUT , HERGENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: A61K31/505 , A61P9/00 , C07D213/64 , C07D239/34 , C07D239/52 , C07D251/22 , C07D403/12
-
公开(公告)号:SK4592000A3
公开(公告)日:2000-12-11
申请号:SK4592000
申请日:1998-10-16
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , HERGENRODER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: A61K31/505 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/5377 , A61P9/02 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07D239/34 , C07D239/36 , C07D239/52 , C07D239/60 , C07D239/70 , C07D401/12 , C07D403/12 , C07D491/048
Abstract: The invention relates to carboxylic acid derivatives of formula (I), wherein the substituents have the meaning as commented in the description. It also relates to the production and use of same as endothelin receptor antagonists.
-
公开(公告)号:BR9907911A
公开(公告)日:2000-10-24
申请号:BR9907911
申请日:1999-02-05
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLING ANDREAS , KLINGE DAGMAR , RIECHERS HARTMUT , DER STEFAN HERGENR , RASCHACK MANFRED , UNGER LILIANE
IPC: A61K31/505 , A61K31/506 , A61P5/14 , A61P9/02 , A61P9/10 , A61P9/12 , A61P11/06 , A61P13/12 , A61P35/00 , A61P43/00 , C07D239/34 , C07D239/46 , C07D239/52 , C07D239/60 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D239/36
Abstract: The invention relates to carboxylic acid derivatives of formula (I), wherein the substituents have the following meanings; R = tetrazole or a group (1); R = a radical OR (2), (3), a 5-membe red heteroaromatic bonded by a nitrogen atom such a pyrrolyl, pyrazolyl, imidazolyl and trizolyl; R , R = hydrogen, hydroxy, NH2, NH(C1-C4-alkyl), N(C1-C4-alkyl)2, halogen, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkinyl, C1-C4-hydroxyalkyl, C1-C4-alkoxy, C1-C4-halogen alkyl, C1-C4-alkoxy, C1-C4-halogen alkoxy or C1-C4-alkythio; X = halogen, C1-C4-halogen alkyl, hydroxy; R and R = phenyl or naphthyl, C3-C7-cycloalkyl, phenyl or naphthyl which are bonded in ortho position by a direct bond, a methylene, ethylene or ethenylene group, an oxygen or sulfur atom or an SO2-NH or an N-alkyl group or a 5-membered or 6-membered heteroaromatic; R = hydrogen, phenyl or naphthyl, a five or six-membered heteroaromatic, C1-C8-alkyl, C3-C6-alkenyl, C3-C6-alkinyl or C3-C8-cycloalkyl, whereby said radicals can be substituted once or many times, with the proviso that R can only stand for hydrogen if Z does not represent a single bond; Z = sulfur, oxygen or a single bond, in addition to the physiologically compatible salts and the enantiomeric-pure and diastereomeric-pure forms. The novel compounds are suitable for combating diseases, especially as endothelin antagonists.
-
-
-
-
-
-
-
-
-